Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients (Q46598130)

23 December 2017

title

Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients (English)

1 reference

23 December 2017

1 reference

S Yoshida

1

1 reference

23 December 2017

T Takeuchi

2

1 reference

23 December 2017

T Kotani

3

1 reference

23 December 2017

N Yamamoto

4

1 reference

23 December 2017

K Hata

5

1 reference

23 December 2017

K Nagai

6

1 reference

23 December 2017

T Shoda

7

1 reference

23 December 2017

S Takai

8

1 reference

23 December 2017

S Makino

9

1 reference

23 December 2017

T Hanafusa

10

1 reference

23 December 2017

publication date

5 September 2013

1 reference

23 December 2017

Journal of Human Hypertension

published in

1 reference

23 December 2017

volume

28

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

165-169

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/jhh.2013.80

exact match

0 references

cites work

An update on the relationships between rheumatoid arthritis and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

The mortality of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Leflunomide and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Preactivated peripheral blood monocytes in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Reproducibility of ambulatory blood pressure monitoring in daily practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Morning rise in blood pressure is a predictor of left ventricular hypertrophy in treated hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Morning blood pressure hyper-reactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Oxidative stress by peripheral blood mononuclear cells is increased in hypertensives with an extreme-dipper pattern and/or morning surge in blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Effects of Interleukin-1 on Blood Pressure, Sympathetic Nerve Activity, and Pituitary Endocrine Functions in Anesthetized Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.80

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

21 January 2018

1 reference

12 December 2020

Association between blood pressure variability and inflammatory marker in hypertensive patients

1 reference

12 December 2020

Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity

1 reference

12 December 2020

Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis

1 reference

12 December 2020

Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT Study. Hypertension and Lipid Trial Study Group

1 reference

12 December 2020

Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis

1 reference

12 December 2020

Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus.

1 reference

12 December 2020

Time for focus on morning hypertension: pitfall of current antihypertensive medication

1 reference

12 December 2020

Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

1 reference

12 December 2020

Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis

1 reference

12 December 2020

Tumor necrosis factor-alpha-angiotensin interactions and regulation of blood pressure

1 reference

12 December 2020

Identifiers

DOI

10.1038/JHH.2013.80

1 reference

23 December 2017

PubMed ID

24005958

1 reference

23 December 2017